VentriPoint Diagnostics Ltd.
VPTDF
$0.0923
$0.012315.38%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -100.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -100.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -100.00% | |||
| SG&A Expenses | -7.96% | -15.23% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -14.84% | -18.60% | |||
| Operating Income | 21.46% | 14.20% | |||
| Income Before Tax | 18.10% | 10.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.65% | 17.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.65% | 17.48% | |||
| EBIT | 21.46% | 14.20% | |||
| EBITDA | 21.50% | 14.20% | |||
| EPS Basic | 12.77% | 18.97% | |||
| Normalized Basic EPS | 18.75% | 11.11% | |||
| EPS Diluted | 12.77% | 18.97% | |||
| Normalized Diluted EPS | 18.75% | 11.11% | |||
| Average Basic Shares Outstanding | 0.79% | 2.43% | |||
| Average Diluted Shares Outstanding | 0.79% | 2.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||